Abstract: A gait evaluating system including a processor is provided. The processor identifies whether a gait type of the user belongs to a normal gait, a non-neuropathic gait or a neuropathic gait based on step feature values of a user and walking limb feature values of the user. In response to that the gait type of the user belongs to the non-neuropathic gait, the processor controls the display panel to display a first auxiliary information, a second auxiliary information, and a third auxiliary information. The first auxiliary information indicates a potential sarcopenia of the user. The second auxiliary information indicates a dietary guideline for muscle building and muscle strengthening. The third auxiliary information shows a motion instruction video for regaining or maintaining muscle strength of the user.

Abstract: The invention encompasses pharmaceutical compositions and methods for using Compound 1 in combination with other agents for treating patients with AIDS or HIV infection.

Abstract: The invention encompasses pharmaceutical compositions and methods for treating AIDS and HIV infection employing Compound 1.

Abstract: The invention encompasses pharmaceutical compositions and methods for using Compound 1 in combination with other agents for treating patients with AIDS or HIV infection.

Abstract: The invention encompasses pharmaceutical compositions and methods for using Compound 1 in combination with other agents for treating patients with AIDS or HIV infection.

Abstract: A method of inhibiting HIV infection in a mammal by administering to said mammal in need thereof a small molecule compound having a molecular weight of less than about 1,000 dalton, wherein said compound interacts with HIV-gp120 in such a manner as to cause conformational change in said gp120 thereby preventing interaction between said gp120 and leukocyte CD4.

Abstract: This invention provides a method of screening a sample for susceptibility to a viral entry inhibitor. The invention further provides a method for monitoring a patient for sensitivity to a viral entry inhibitor and a method of determining an inhibitory concentration of a viral entry inhibitor to inhibit virus infection in a patient. A method of screening for viral entry inhibitors is also provided.

Abstract: This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with indoleoxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.

Abstract: The present invention is directed to the use of pharmaceutical compositions containing anti-retroviral effective amounts of (a) d4T and (b) 5-fluorouracil or a prodrug, or salt thereof.

Abstract: A method for engraving a grid pattern on a slide or slip is described which employs a photographic technique to create a grid pattern image in a photoresist coating on the slide or slip. Development and etching produce the engraved slide or slip. They are useful for accurate and repeated identification of cultured or manipulated cells growing thereon.